Catheter Precision, Inc. Payments to Acquire Debt Securities, Available-for-sale
Catheter Precision, Inc. (VTAK) reported Payments to Acquire Debt Securities, Available-for-sale of $36.46 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2021-03-17
- Catheter Precision, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2019-12-31 was $0.00.
- Catheter Precision, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2019-09-30 was $0.00.
- Catheter Precision, Inc. payments to acquire debt securities, available-for-sale for fiscal 2019 was $36.46M.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $0.00 derived: sum of 2 quarters · filed 2021-03-17 | $36.46M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $36.46M 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $36.46M 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |